drug delivery

  • Chitosan for vaccine development against SARS-CoV-2

    Published on

    The global spread of SARS-CoV-2 can only be contained through vaccine development. Vector vaccines (DNA and viral) can be produced rapidly and inexpensively with current synthesis technologies. Challenges with DNA vaccines include degradation by DNases, inefficient uptake by antigen-presenting cells, and low immunogenicity. The Quil-A-loaded chitosan particulate adjuvant system (QAC) enables transport of plasmid DNA directly to target cells and delayed release over time. Here, we present two recent studies about chitosan-based delivery systems for vaccines.

     Read more: Chitosan for vaccine development against SARS-CoV-2

  • Water-soluble drug release by chitosan microparticles

    Published on

    Chitosan and chitosan derivatives are promising biopolymers for nasal or vaginal drug delivery using micro- or nanoparticles. However, the pH-dependent solubility of chitosan and excessive water uptake in the presence of ions is suboptimal. Water uptake can result in rapid initial release of the drug due to collapse of the chitosan-based transport vehicle. To stabilize the drug release, research is being conducted to modify the polymer structure by physical crosslinking. Aim of the presented study was to investigate the influence of microparticle composition, in particular the amount of ion crosslinker (CF) introduced, on the release profile of water-soluble drugs from the chitosan matrix.

     Read more: Water-soluble drug release by chitosan microparticles

  • Chitosan implants for regenerative medicine

    Published on

    In recent decades, there have been major advances in regenerative medicine, such as the treatment of severe nerve injuries. Implants used as scaffolds for nerve cell regeneration are often made of biodegradable polymers, such as chitosan. Below, we present a study that investigated the degradation and stability of tubular chitosan-based implants.

     Read more: Chitosan implants for regenerative medicine

  • Chitosan as adjuvant for vaccines

    Published on

    Adjuvants in vaccines are potent enhancers, which ensure that even small amounts of pathogens induce a permanent immune response. They are particularly necessary for inactivated vaccines and vaccines with antigen subunits. Several studies investigated chitosan as an adjuvant or antigen delivery system in various formulations (gels, aqueous dispersion, micro- and nanoparticles).

     Read more: Chitosan as adjuvant for vaccines

  • Publications with chitosan and chitosan derivatives by HMC in 2018

    Published on

    Worldwide, our chitosan and chitosan derivatives are used in research. We created a list of scientific articles published in 2018 using chitosan from HMC. Nanoparticles from chitosan or chitosan derivatives were most frequently produced and tested for a wide variety of applications, mainly directed drug delivery and tissue engineering. Curious where to find chitosan by HMC in research?

     Read more: Publications with chitosan and chitosan derivatives by HMC in 2018

  • Drug delivery systems with chitosan

    Published on

    Biological barriers can limit the availability of a therapeutic agent in the target tissue. Drug delivery systems overcome these limitations to transport the correct dose of drug to its target site. The biopolymer chitosan has great potential for the development of innovative drug delivery systems. We present two articles that explore the treatment of cancer and noise-induced hearing loss with chitosan-based drug delivery systems.

     Read more: Drug delivery systems with chitosan

  • Publications in March 2017 - antimicrobial activity of chitosan

    Published on

    In March 2017, 215 articles were released about chitosan and chitosan derivatives. The top three nations in chitosan research are China (59), India (32) and USA (27). Main focuses were nanoparticels, evaluation studies and pharmaceutical preparations.

     Read more: Publications in March 2017 - antimicrobial activity of chitosan

  • Publications in July & August 2016 - drug delivery systems

    Published on

    Today´s topic is chitosan for drug delivery systems. In July and August 2016, 33 articles about chitosan combined with drug delivery systems were published. As might be expected, top publisher are China (13 articles), United States (5) and India (4). The articles investigated drug release by chitosan-based micro- or nanoparticles, hydrogels and nanocomposites. Thereby controlled release of cytostatics, proteins or peptides was mainly studied. (Source: www.gopubmed.org)

     Read more: Publications in July & August 2016 - drug delivery systems

  • Publications in April 2016 - Tissue Engineering

    Published on

    In April 2016, 268 publications about chitosan were released. In addition to China (52) and the United States (25), Brazil (15) is on the third place of nations with the most publications. The following studies deal with chitosan as drug delivery system to support regeneration of dermal tissue or articular cartilage.

     Read more: Publications in April 2016 - Tissue Engineering

  • Publication May and June 2013

    Published on

    231 articles about chitosan and chitosan derivatives have been published in May and June 2013. The main topics focused on animal and human studies and on chitosan-based nanoparticles and pharmaceutical preparations. Moreover, the physico-chemical properties and pH sensitivity of various chitosan derivatives were intensively studied. Among the top nations of chitosan research are again: China (76 articles), USA (30) and India (14).

     Read more: Publication May and June 2013

  • Publications in March and April 2014

    Published on

    In March and April, 234 publications were released about Chitosan, mainly addressing topics like pharmaceutical preparations, nanoparticles, evaluation studies and tissues. The most successful nations in the field of chitosan-related publications are again: China (74 articles), India (24) and USA (19).

     Read more: Publications in March and April 2014

  • Publications in February 2015

    Published on

    After an excellent start in January 2015, the number of chitosan-related articles slightly decreased in February. Scientific journals released 142 publications, which mainly focused on pharmaceutical preparations, nanoparticles and evaluation studies. Again, the three leading nations in chitosan research are China (40 articles), India (19) and USA (13). German scientists are placed among the top 10, as they contributed 5 reports.

     Read more: Publications in February 2015

  • Publications in January 2015

    Published on

    At the beginning of the year 2015, an incredible large number of chitosan-related articles have been released, indicating another record year. All in all, 196 publications about chitosan and its derivatives were contributed by scientist from all over the world, especially from China (46 articles), India (29) and USA (15). The main terms address chitosan in evaluation studies, nanoparticles and pharmaceutical preparations. 

     Read more: Publications in January 2015

  • Publications in March 2012

    Published on

    Overall 131 articles about chitosan and chitosan derivatives were published in March 2012.

    As in the previous month, China is the country with the most publications with overall 35 articles, followed by the USA (14 articles), India (9 articles) and Taiwan (8 articles).

     

     Read more: Publications in March 2012

  • Publications in September 2010

    Published on

    Besides interesting conferences like the ESB Meeting (European Conference on Biomaterials) from September 11 to 15 in Tampere, Finland many international articles about the application of chitosan appeared. As usual, some interesting papers will be presented.

     Read more: Publications in September 2010

  • Nanoparticles: Trojan Horse for APIs

    Published on

    The big challenge in the field of medical innovations is so tiny that it is not noticeable with the naked eye. Nanotechnology – a promising and trendsetting technology. For example, with the help of drug-delivery-systems drugs can be transported to an exactly defined part within the body.
    Chitosan also produces nanoparticles.

     Read more: Nanoparticles: Trojan Horse for APIs

  • Veröffentlichungen im August 2010

    Published on

    Der Sommer neigt sich zum Ende – das heißt aber nicht, dass die News rund um Chitosan nicht heiß sind. Hier der Review der Chitosan Veröffentlichungen im August. 97 wissenschaftliche Artikel wurden veröffentlicht, in denen mit Chitosan gearbeitet wurde. Im Int J Biol Macromol wurden 8 Artikel veröffentlicht. Die Top drei Nationen bezogen auf die Anzahl der Artikel sind China, USA und Indien, gefolgt von Portugal auf Platz 4.

     Read more: Veröffentlichungen im August 2010

  • Publications in Chitosan Research in 2008

    Published on

    The systematic study on chitosan and its applications also significantly gains in importance in 2008. The number of articles mentioning chitosan in their title and published in biomedical journals rise by 46% compared to the number of 2007 publications. Exploratory focus of the 692 articles were mainly in the areas biotechnology and pharmaceuticals.

     Read more: Publications in Chitosan Research in 2008

Congress and fairs

Meet us in person 2022:

  • EUCHIS, 2022
  • CPHI 2022
  • Medica 2022
  • Asia Pacific Chitin and Chitosan Symposium, 2022, South Korea

To arrange an appointment please contact Katja Richter via sales(at)medical-chitosan.com

Contact

  • Heppe Medical Chitosan GmbH
    Heinrich-Damerow-Strasse 1
    06120 Halle (Saale)
    Germany
  • Tel.: +49 (0) 345 27 996 300
    Fax: +49 (0) 345 27 996 378
  • sales@medical-chitosan.com

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.